NCT00473070View on ClinicalTrials.gov

A Clinical Study of Tobradex AF

PHASE3CompletedINTERVENTIONAL

Enrollment

900

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 28, 2007

Conditions

Cataract

Interventions

DRUG

Tobradex AF

Trial Locations (1)

15122

Pittsburgh, Pittsburgh

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY